199 related articles for article (PubMed ID: 18492023)
1. Living donor liver transplantation in hepatocellular carcinoma beyond the Milan criteria.
Woo HY; Jang JW; Choi JY; You CR; Jeong SW; Bae SH; Yoon SK; Lee YS; Kim DG
Liver Int; 2008 Sep; 28(8):1120-8. PubMed ID: 18492023
[TBL] [Abstract][Full Text] [Related]
2. Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma.
Lo CM; Fan ST; Liu CL; Chan SC; Ng IO; Wong J
Br J Surg; 2007 Jan; 94(1):78-86. PubMed ID: 17016793
[TBL] [Abstract][Full Text] [Related]
3. The role of living-donor liver transplantation in surgical treatment for hepatocellular carcinoma.
Yokoi H; Isaji S; Yamagiwa K; Tabata M; Nemoto A; Sakurai H; Usui M; Uemoto S
J Hepatobiliary Pancreat Surg; 2006; 13(2):123-30. PubMed ID: 16547673
[TBL] [Abstract][Full Text] [Related]
4. Liver transplantation for adult patients with hepatocellular carcinoma in Korea: comparison between cadaveric donor and living donor liver transplantations.
Hwang S; Lee SG; Joh JW; Suh KS; Kim DG
Liver Transpl; 2005 Oct; 11(10):1265-72. PubMed ID: 16184545
[TBL] [Abstract][Full Text] [Related]
5. Living-donor liver transplantation for hepatocellular carcinoma.
Kaihara S; Kiuchi T; Ueda M; Oike F; Fujimoto Y; Ogawa K; Kozaki K; Tanaka K
Transplantation; 2003 Feb; 75(3 Suppl):S37-40. PubMed ID: 12589138
[TBL] [Abstract][Full Text] [Related]
6. Living donor liver transplantation as a second-line therapeutic strategy for patients with hepatocellular carcinoma.
Takada Y; Ueda M; Ito T; Sakamoto S; Haga H; Maetani Y; Ogawa K; Kasahara M; Oike F; Egawa H; Tanaka K
Liver Transpl; 2006 Jun; 12(6):912-9. PubMed ID: 16489583
[TBL] [Abstract][Full Text] [Related]
7. Comparison between human-telomerase reverse transcriptase mRNA and alpha-fetoprotein mRNA as a predictive value for recurrence of hepatocellular carcinoma in living donor liver transplantation.
Oya H; Sato Y; Yamamoto S; Nakatsuka H; Kobayashi T; Hara Y; Waguri N; Suda T; Aoyagi Y; Hatakeyama K
Transplant Proc; 2006 Dec; 38(10):3636-9. PubMed ID: 17175353
[TBL] [Abstract][Full Text] [Related]
8. Liver transplantation outcomes for early-stage hepatocellular carcinoma: results of a multicenter study.
Leung JY; Zhu AX; Gordon FD; Pratt DS; Mithoefer A; Garrigan K; Terella A; Hertl M; Cosimi AB; Chung RT
Liver Transpl; 2004 Nov; 10(11):1343-54. PubMed ID: 15497158
[TBL] [Abstract][Full Text] [Related]
9. Living donor liver transplantation for hepatocellular carcinoma: a single-center preliminary report.
Malagó M; Sotiropoulos GC; Nadalin S; Valentin-Gamazo C; Paul A; Lang H; Radtke A; Saner F; Molmenti E; Beckebaum S; Gerken G; Frilling A; Broelsch CE
Liver Transpl; 2006 Jun; 12(6):934-40. PubMed ID: 16528715
[TBL] [Abstract][Full Text] [Related]
10. Living donor liver transplantation for hepatocellular carcinoma: a special reference to a preoperative des-gamma-carboxy prothrombin value.
Shimada M; Yonemura Y; Ijichi H; Harada N; Shiotani S; Ninomiya M; Terashi T; Yoshizumi T; Soejima Y; Maehara Y
Transplant Proc; 2005 Mar; 37(2):1177-9. PubMed ID: 15848661
[TBL] [Abstract][Full Text] [Related]
11. Can we expand the Milan criteria for hepatocellular carcinoma in living donor liver transplantation?
Lee KW; Park JW; Joh JW; Kim SJ; Choi SH; Heo JS; Lee HH; Lee DS; Park JH; Yoo BC; Paik SW; Koh KC; Lee JH; Choi MS; Lee SK
Transplant Proc; 2004 Oct; 36(8):2289-90. PubMed ID: 15561222
[TBL] [Abstract][Full Text] [Related]
12. [Indication of liver transplantation for hepatocellular carcinoma: Shanghai Fudan Criteria].
Fan J; Zhou J; Xu Y; Qiu SJ; Wu ZQ; Yu Y; Huang XW; Tang ZY; Wang YQ
Zhonghua Yi Xue Za Zhi; 2006 May; 86(18):1227-31. PubMed ID: 16796876
[TBL] [Abstract][Full Text] [Related]
13. [Living donor liver transplantation for the patient with hepatocellular carcinoma].
Taketomi A; Soejima Y; Yoshizumi T; Uchiyama H; Maehara Y
Gan To Kagaku Ryoho; 2004 Dec; 31(13):2118-21. PubMed ID: 15628755
[TBL] [Abstract][Full Text] [Related]
14. Feasibility of salvage liver transplantation for patients with recurrent hepatocellular carcinoma.
Hu RH; Ho MC; Wu YM; Yu SC; Lee PH
Clin Transplant; 2005 Apr; 19(2):175-80. PubMed ID: 15740552
[TBL] [Abstract][Full Text] [Related]
15. Recurrence rate and transplantability after liver resection in patients with hepatocellular carcinoma who initially met transplantation criteria.
Tanaka H; Kubo S; Tsukamoto T; Shuto T; Takemura S; Yamamoto T; Okuda T; Kanazawa A; Hirohashi K
Transplant Proc; 2005 Mar; 37(2):1254-6. PubMed ID: 15848687
[TBL] [Abstract][Full Text] [Related]
16. Microvascular tumor embolism: independent prognostic factor after liver transplantation in hepatocellular carcinoma.
Lee HH; Joh JW; Park JH; Lee KW; Heo JS; Choi SH; Kim SJ; Lee SK
Transplant Proc; 2005 Mar; 37(2):1251-3. PubMed ID: 15848686
[TBL] [Abstract][Full Text] [Related]
17. Liver transplantation for patients with hepatocellular carcinoma.
Ho MC; Wu YM; Hu RH; Ko WJ; Yang PM; Lai MY; Lin MH; Lin HY; Lee PH
Transplant Proc; 2004 Oct; 36(8):2291-2. PubMed ID: 15561223
[TBL] [Abstract][Full Text] [Related]
18. The role and limitation of living donor liver transplantation for hepatocellular carcinoma.
Lo CM; Fan ST; Liu CL; Chan SC; Wong J
Liver Transpl; 2004 Mar; 10(3):440-7. PubMed ID: 15004774
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes of living donor liver transplantation for hepatitis C virus (HCV)-positive patients.
Takada Y; Haga H; Ito T; Nabeshima M; Ogawa K; Kasahara M; Oike F; Ueda M; Egawa H; Tanaka K
Transplantation; 2006 Feb; 81(3):350-4. PubMed ID: 16477219
[TBL] [Abstract][Full Text] [Related]
20. Alpha-fetoprotein mRNA detection in peripheral blood for prediction of hepatocellular carcinoma recurrence after liver transplantation.
Marubashi S; Dono K; Sugita Y; Asaoka T; Hama N; Gotoh K; Miyamoto A; Takeda Y; Nagano H; Umeshita K; Monden M
Transplant Proc; 2006 Dec; 38(10):3640-2. PubMed ID: 17175354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
